| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18507 R79826 |
Broe (Controls unexposed, general pop), 2025 | Major congenital malformations (exclusion of chromosomal abnormalities (ICD-10 codes Q90– Q99)) | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) excluded | Adjustment: Yes Paracetamol use: prescription or medical files |
1.12 [1.01;1.26] excluded (control group) |
384/8,590 16,928/471,855 | 17,312 | 8,590 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18508 R79827 |
Broe (Controls unexposed, sick), 2025 | Major congenital malformations (exclusion of chromosomal abnormalities (ICD-10 codes Q90– Q99)) | 1st trimester | population based cohort retrospective | unexposed, sick | Adjustment: Yes Paracetamol use: prescription or medical files | 1.00 [0.87;1.15] | 384/8,590 646/14,817 | 1,030 | 8,590 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18496 R78615 |
Xu, 2024 | Congenital disabilities | during pregnancy (anytime or not specified) excluded | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files |
0.70 [0.41;1.17] excluded (exposition period) |
26/501 37/501 | 63 | 501 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18630 R79319 |
Poletta, 2012 | Single or multiple birth defects (excluding minor anomalies and syndromes) | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.25 [1.17;1.33] C | 1,788/4,518 56,726/164,810 | 58,514 | 4,518 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18505 R79320 |
Rebordosa a, 2008 | Major congenital abnormalities | 1st trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 1.01 [0.93;1.08] | 1,132/26,424 2,652/61,718 | 3,784 | 26,424 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18595 R78997 |
Thulstrup, 1999 | Malformations (ICD-8 or ICD-10) | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files | 2.28 [0.97;5.36] | 6/55 697/13,327 | 703 | 55 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18536 R78726 |
Aselton, 1985 | Any congenital disorders (malformations) | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Paracetamol use: prescription or medical files | 0.34 [0.08;1.38] C | 2/350 103/6,159 | 105 | 350 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18776 R79889 |
Nelson, 1971 | All abnormalities | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Matched Paracetamol use: maternal ITW/questionnaires after pregnancy Paracetamol use: prescription or medical files | 0.88 [0.27;2.88] C | 4/13 454/1,356 | 458 | 13 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 6 studies | 1.09 [0.93;1.29] | 64,594 | 39,950 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick;
Asymetry test p-value = 0.6566 (by Egger's regression)
slope=0.1530 (0.0837); intercept=-0.7222 (1.5063); t=0.4795; p=0.6566
excluded 18507